• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Synergy Pharmaceuticals

anonymous board for Synergy Pharmaceuticals
Replies
26
Views
5K
anonymous
Replies
16
Views
3K
anonymous
Replies
0
Views
1K
anonymous
Replies
12
Views
2K
anonymous
Replies
12
Views
3K
anonymous
Replies
6
Views
6K
anonymous
Replies
3
Views
1K
anonymous
Replies
14
Views
2K
anonymous
Replies
7
Views
1K
anonymous
Replies
5
Views
1K
anonymous
Replies
7
Views
2K
anonymous
Replies
22
Views
5K
anonymous
Replies
49
Views
7K
anonymous
Replies
8
Views
1K
anonymous
Replies
3
Views
898
anonymous
Replies
2
Views
1K
anonymous
Replies
7
Views
2K
anonymous
Replies
1
Views
2K
anonymous
Replies
0
Views
2K
anonymous